The objective of the present study was to investigate the association between gene E-cadherin single nucleotide polymorphisms (SNPs) and risk of developing endometriosis in Indian women and to evaluate the role of E-cadherin expression in the pathophysiology of endometriosis. A genetic association study was conducted in 715 endometriosis cases and 500 controls of Indian origin. We genotyped 2160 C/A, +54 C/T and 2347 G/GA SNPs of gene E-cadherin by PCR-sequencing and PCR-restriction fragment length polymorphism techniques. Haplotype frequencies for multiple loci and the standardized disequilibrium coefficient (D ′ ) for pair-wise linkage disequilibrium (LD) were assessed by Haploview Software. In addition, to better understand genetic contributions to the pathophysiology of endometriosis, the expression pattern of E-cadherin in the endometrium of women with and without endometriosis was analyzed by western blot and immunohistochemical analysis. The frequencies of 2347GA/GA (P ¼ 0.026) and 2160A/A (P ¼ 0.0019) genotypes and 2347G/2160A/+54C (P ¼ 0.007) and 2347GA/2160A/+54C (P , 0.0001) haplotypes were significantly different between patients and controls. Strong LD was observed between 2347G/GA and 2160C/A loci (D ′ ¼ 0.64) when compared with 2347G/GA and +54C/T (D ′ ¼ 0.585) or 2160C/A and +54C/T (D ′ ¼ 0.05) loci in cases. Furthermore, increased membranous E-cadherin expression was observed in cases than in controls. The expression seems to be genotype dependent. In conclusion, the E-cadherin 2347GA/GA and 2160A/A genotypes and 2347GA/2160A/+54C and 2347G/2160A/+54C haplotypes may jointly modify the risk of endometriosis in Indian women. In addition, the differential expression of E-cadherin may play an important role in pathogenesis of endometriosis.
Introduction
Endometriosis is a chronic gynecological disorder that occurs in 10% of women of reproductive age and in up to 50% of women with infertility (Eskenazi and Warner, 1997) . It is characterized by the presence of endometrium-like tissue outside the uterine cavity. Although endometriosis is a benign lesion, it often displays characteristics that are associated with malignancy. It can invade into the abdominal tissues and the viscera and has a 'metastatic pattern' of spread (Spuijbroek et al., 1992) . The most widely accepted theory regarding the pathogenesis of endometriosis involves the implantation and invasion of the viable cells from retrograde menstruation into the peritoneum (Simpson, 1927) . Lack of cell adhesion must play a major role in the migration of cells to ectopic sites but to date, the mechanisms by which cell adhesion molecules mediate the development of human endometriosis remains unclear. Previously we demonstrated the correlation between single nucleotide polymorphisms (SNPs) of various candidate genes and endometriosis in Indian population (Bhanoori et al., 2008; 2005a, b) . The emerging evidence strongly suggests that the disease has a polygenic and multifactorial basis (Tempfer et al., 2009) .
Cadherins constitute a gene superfamily of integral membrane glycoproteins that mediate and regulate Ca 2+ -dependent homophilic cell-cell adhesion and modulate a wide variety of processes, including cell polarization, migration and cancer metastasis (Takeichi, 1990; Wheelock and Johnson, 2003 ). E-cadherin or CDH1 (16q22.1) is an epithelial cellular junction protein expressed in almost all epithelial cells. It is an invasion-suppressor molecule, plays an important role in the maintenance of epithelial development, organization and cell integrity (Frixen et al., 1991) . Diminished expression of CDH1 promotes malignant transformation, tumor invasion and metastasis. Reduced expression of CDH1 has been observed in a series of different cancers (Risinger et al., 1994) . Normal endometrium shows intense CDH1 expression throughout the menstrual cycle (Poncelet et al., 2002) , whereas the reported expression of CDH1 in the endometriotic lesions has been inconsistent. The 2160C/A and 2347G/GA are two common SNPs located in upstream from the transcriptional start site of CDH1, which may modulate the transcriptional efficiency of the gene (Li et al., 2002; Nakamura et al., 2002; Shin et al., 2004) . In addition, a C to T transition polymorphism at position +54 after the stop codon of CDH1 was linked with the mRNA stability (Becker et al., 1995; Keirsebilck et al., 1998) . These polymorphisms were associated with the development and progression of various human cancers. As far as we know, little investigation has been carried out on the association between CDH1 polymorphisms and endometriosis (Hsieh et al., 2005; Shan et al., 2007) . The present study was conducted to analyze the prevalence of CDH1 polymorphisms with the risk of developing endometriosis in two ethnically different Indian populations. In addition, to better understand genetic contributions to the pathophysiology of endometriosis, the expression pattern of CDH1 in the endometrium of women with and without endometriosis was also analyzed.
Materials and Methods

Study design
Two independent case -control groups were recruited from two ethnically different linguistic groups of Indian subcontinent (Reich et al., 2009) . A total of 715 premenopausal unrelated Indian women with moderatesevere (III -IV) endometriosis staged using the revised American Fertility Society (rAFS) classification system (1997), Hyderabad, India (South Indian or Dravidian linguistic group, n ¼ 370) and Institute of Reproductive Medicine (IRM), Kolkata, India (North Indian or Indo-European linguistic group, n ¼ 345). All women had a trans-vaginal ultrasound scan (TVS) at screening followed by a laparoscopy to confirm the diagnosis (rAFS III ¼ 259; IV ¼ 456). All the patients had different forms of endometriosis such as peritoneal lesions, adhesions and endometrioma. Women with other ovarian cysts, adenomyosis, ovarian cancer, fibroids and Stage I and II endometriosis were excluded from the study. The aim was to focus on patients with more severe endometriosis (Stages III and IV) because the more severe forms include ovarian cystic disease, which almost certainly has a different etiology to peritoneal forms, and the diagnosis is usually unequivocal, which is not the case for Stages I and II. Their mean age + SD was 26.5 + 5.5 (range: 20 -40) years. All the patients complained of dysmenorrhoea (mild, 45%; moderate, 31% and severe, 24%) and 75% had dyspareunia. Most women (98.1%) were infertile (primary, 82% and secondary, 18%).
Five hundred women (250 of each from IRM and IIRC) were recruited from the same clinic population and had an equal opportunity to be identified as cases, thereby meeting the criteria for appropriate controls set by Zondervan et al. (2002) . The controls consisted of 431 (86.2%) women with no evidence of endometriosis on TVS, laparoscopy and 69 (13.8%) women with no evidence of an ovarian endometrioma on TVS (and no clinical symptoms of endometriosis) who therefore did not subsequently had a laparoscopy. Their mean age + SD was 27.9 + 4.95 (range: 22 -40). Seventy-six percent had primary and 24% had secondary infertility. Written informed consent was obtained from all participants. The Institutional Review Board of the Centre for Cellular and Molecular Biology, Hyderabad, approved the study.
Tissue collection
Secretory phase endometrial tissue was obtained from the uterine fundus by curettage at the time of laparoscopy. Each sample was divided into two portions: one was immediately immersed in 4% paraformaldehyde in 0.05 M of Tris -HCl buffer (pH 7.4) at 48C for at least 24 h and embedded in paraffin for histological examination. Another portion was rinsed in ice cold phosphate-buffered saline on ice to remove excess blood and then rapidly frozen in liquid nitrogen and stored at 2708C for subsequent immunoblot assay. Histological assessment of endometrial morphology was carried out using standard criteria (Noyes et al., 1950) .
DNA extraction
Genomic DNA was extracted from 1 ml of EDTA anti-coagulated whole blood by the salting out method (Miller et al., 1988) . The genotypes of CDH1 2160C/A and +54C/T SNPs were analyzed by PCR and sequencing analysis, while the 2347G/GA genotypes (insertion mutation) were determined by PCR-restriction fragment length polymorphism method (PCR-RFLP). Both cases and controls were genotyped in a randomized, blinded fashion.
Determination of the CDH1genotype
PCRs were carried out in a total volume of 25 ml, containing 50 ng genomic DNA, 2 -6 pmole of each primer, 1× Taq polymerase buffer (1.5 mM MgCl 2 ) and 0.25 U of Amplitaq DNA polymerase (Perkin Elmer, USA). The primers and PCR conditions used were given in Table I . The PCR products of 448 bp (2160C/A) and 172 bp (+54C/T) were analyzed by 1.5% agarose gel then sequenced with a Taq-Dye deoxyterminator cycle sequencing kit (Applied BioSystems, USA) using an automated ABI 3770 DNA sequencer (Applied BioSystems). Genotype calling was performed using Chromas V.2 software (Technelysium Ltd., Australia). For PCR-RFLP genotyping of 2347G/GA polymorphism, 8 ml of PCR product (448 bp) was digested at 378C overnight in a 10 ml reaction containing 10 U of BanII (New England Biolabs). DNA fragments were electrophoresed through a 3% agarose gel and stained with ethidium bromide. The GA alleles were represented by DNA bands of sizes of 332 and 116 bp and the G alleles were represented by a DNA bands of sizes of 263, 116 and 68 bp, whereas the heterozygotes displayed a combination of both alleles (332, 263, 116 and 68 bp; Fig. 1 ).
Immunohistochemical analysis
Immunohistochemical analysis of CDH1expression was performed on the sections of secretory phase endometrial tissue from cases (n ¼ 5) and controls (n ¼ 4), using the method described by Bhanoori et al. (2008) . After incubation with FITC-conjugated secondary goat anti-rabbit antibody (1:1000, Sigma -Aldrich, USA), the sections were washed and mounted with an antifade mounting medium (Vector Lab, USA) then visualized using an Axioplan 2 epifluorescence microscope (Carl Zeiss, Inc., USA). DAPI (4 ′ ,6 ′ diamidino-2-phenylindole) was used to counterstain the nuclei. Negative controls were obtained by substituting CDH1 antibody with the non-immune rabbit serum.
Western blot analysis
Protein extraction and western blot analysis were performed (cases ¼ 4; controls ¼ 4) as per the protocol described by Bhanoori et al. (2008) . After incubation with horseradish peroxidase-conjugated secondary antibody (Sigma), the membrane was washed and the antigen -antibody complexes were detected using a chemiluminescence reagent kit (GE health care, USA). Band intensity in the western blots was determined using image J software.
Statistical analysis
Statistical analysis was performed using SPSS statistical package (V 11.0). The genotype distribution among subjects was tested for Hardy -Weinberg equilibrium (HWE) using Fisher's exact test. The allele ratios and genotype distributions of cases and controls were analyzed with Pearson x 2 or Fisher's exact test. Haplotype frequencies for multiple loci and the standardized disequilibrium coefficient (D ′ ) for pair-wise linkage disequilibrium (LD) were assessed by Haploview Software (Barrett et al., 2005) . The odds ratio and 95% confidence interval (CI) values were calculated using the online Vassar Stats Calculator (http ://www.faculty.vassar.edu/lowry/VassarStats.html). The sample power was analysed by Compare2 software (Abramson, 2011) . The Student's t-test was used to analyze differences between immunoblot band densities; P , 0.05 was considered statistically significant based on three or more independent experiments. Significance values were corrected by the Bonferroni method.
Results
All 715 cases and 500 controls were successfully genotyped. Amongst both cases and controls, the genotype distributions of individual SNPs as well as CDH1 allele system were all in HWE (P . 0.05). Sequencing analysis of 448 bp (2160C/A) and 172 bp (+54C/T) PCR products were shown in Fig. 2A and B. The CC, AA (2160) and CC, TT (+54) homozygotes manifested as a single peak, whereas heterozygotes CA (2160) and CT (+54) as double peaks.
Genotyping of CDH1 polymorphisms
The 2347G/GA genotype distribution and allele frequencies amongst the 715 cases and 500 controls were shown in Table II . Although the allele frequencies were not significantly different between cases and controls (P ¼ 0.353), the genotype frequency distribution exhibited significant variation (P ¼ 0.026), which resulted from an increased proportion of homozygous GA/GA genotype among patients as compared with controls.
The genotype and allelotype distribution of the 2160C/A SNP revealed significant difference between patients and controls (all P values , 0.05). There was significant reduction in 'CC' genotype frequency and elevation of 'AA' genotype frequency in endometriosis cases as compared with controls (P ¼ 0.001). The allele frequency also showed significant difference (P , 0.0001), indicating that the 'A' allele might confer to endometriosis risk and the 'C' allele offers protection against the disease.
The frequencies of genotypes (P ¼ 0.6) and allelotypes (P ¼ 0.47) of the +54C/T polymorphism were not significantly different between cases and controls (Table II) . The genotype and allele distribution showed high prevalence of 'C' allele in Indian women.
The Indian population is ethnically different (Reich et al., 2009 ), so we performed statistical analysis independently for both North (Indo-European) and South Indian (Dravidian) women (Supplementary data, Tables SIA, B and SIIA, B). Our study provides very good evidence of ethnic differences leading to different association statuses. The analysis surprisingly revealed two different scenarios in the two groups. We found no association between the 2347G/GA polymorphism and endometriosis in the Dravidian group (Supplementary data, Table  SIIA) ; however, the Indo-European group showed strong association of this polymorphism with endometriosis (Supplementary data, Table  SIA ). In addition, the allele and genotype frequencies of +54C/T SNP were considerably different between two groups. The study, apart from presenting useful data for these populations of India, also brings forward important issue of variation in association levels due to ethnicity.
Haplotype analysis
To analyze the combined effect of CDH1 SNPs on endometriosis development, the haplotype frequencies were estimated (Table III) . There was strong linkage disequilibrium between 2347G/GA and (Fig. 3A) . In contrast, we observed strong linkage disequilibrium between 2347G/GA and +54C/T loci (D ′ ¼ 0. 
Immuhistochemistry of CDH1
Immunostaining of CDH1 was more intense in the surface and glandular epithelial cells of endometrium, but undetectable in the stromal cells. CDH1 was present in almost all cases and controls. In some sections, fluorescence was seen in red blood cells, but they did not pick up DAPI as they are anucleated. We observed increased membranous CDH1 expression in cases than in controls (Fig. 4) .
Western blot analysis
Western blot analysis confirmed the immunohistochemical data. The case endometrial samples exhibited higher levels of CDH1expression than the controls (Fig. 5) .
Discussion
The present study showed significant association between CDH1 2160C/A, 2347G/GA polymorphisms and endometriosis risk in Indian women. Shan et al. (2007) reported no association between 2160C/A, 2347G/GA polymorphisms and endometriosis in north Chinese women, which is not in agreement with the present result. Possible reasons for this discrepancy could be: first, ethnic variation observed in the SNPs analysed. Indeed drastic difference in the 'A' allele distribution was observed in the two populations studied. The frequencies of 'A' allele in their controls and cases were 19.6 and 16.8%, respectively, compared with 22 and 29.44% in the present study. Second, the sample size in their study is much smaller than that of the present study.
The 2160C/A and 2347G/GA SNPs are at the upstream of the transcriptional start site of CDH1 gene. Several cis-acting elements such as E boxes, CAAT box, SP1-binding site, etc. are present within the proximity of above sites (Giroldi et al., 1997) . Hence, they have significant effects on the transcriptional activity of CDH1 gene. The 2160A allele decreases the transcriptional efficiency by 68% when compared with the 'C' allele in vitro (Li et al., 2002) , whereas the 2347GA allele reduces the transcriptional efficiency by 10-fold and has a weak transcription factor binding strength when compared with the 'G' allele (Shin et al., 2004) . Thus, the above allelic variations may act as potential genetic markers for diseases with high invasive or metastatic nature.
There are very few reports regarding the effect of the +54C/T SNP on the development of tumors. It is suspected that the +54C/T SNP down-regulate CDH1 expression by modulating the mRNA stability (Keirsebilck et al., 1998) . Our results showed no association between +54C/T SNP and risk of developing endometriosis in Indian women. The data are inconsistent with the previously reported findings (Hsieh et al., 2005; Shan et al., 2007) . Moreover, our results indicate higher risk of endometriosis for 2347GA/2160A/+54C haplotype. As per our results it is one of the rarest haplotypes in Indian women. It has two mutated alleles (GA and A) out of three. This may be one of the reasons for its low frequency in both cases (48/715) and controls (5/500) in comparison with other haplotypes. However, its relative frequency in the cases was 6.7-times higher than that in the controls. It indicates the significance of this haplotype in pathogenesis of endometriosis. Furthermore, the 2347GA/2160A/+54C haplotype exhibits two broad categories of alleles: the first category alleles (2347GA; 2160A) are mutated version that decrease the transcriptional efficiency, while the second category allele is a wild type (+54C). In this context, we are hypothesizing that the decreased expression of CDH1 by first category alleles may play a crucial role in the shedding of viable cells from endometrium and in its metastatic pattern of spread. Whereas the increased CDH1 expression by the removal of the negative transcriptional effect of first category alleles by an unknown mechanism may lead to the implantation of cells on ectopic sites. Here the presence of second category wild-type allele (+54C) at third loci is also crucial as it does not alter the CDH1 expression at post-transcriptional level unlike to its relative mutated allele (+54T). However, further functional studies are necessary to confirm our findings.
The loss of CDH1 expression may be a crucial mechanism in the pathogenesis of endometriosis. Previous reports showed that Ecadherin is predominantly expressed in the glandular and surface epithelial cells of endometrium, but not in the stroma (Van der Linden et al., 1995; Poncelet et al., 2002) . Our results are in agreement with this finding. According to Van der Linden et al. (1995) , differential expression of CDH1 might be involved in the shedding of endometrial tissue during menstruation and the attachment of endometrial tissue fragments to the peritoneal lining during retrograde menstruation. Persistence of fibronectin expression around endometriotic glands but not in endometrium despite menstruation in corresponding eutopic endometrium indicates that CDH1 could play a role in the persistence of endometriotic lesions (Beliard et al., 1997) . Endometriotic cells have been found to be non-malignant epithelial cells lacking CDH1 which were invasive in an in vitro collagen invasion assay (Gaetje et al., 1997) . Uncertain results have been reported regarding the expression of CDH1 in endometriosis. Some studies reported reduced E-cadherin polymorphism and endometriosis expression of CDH1 in the glandular epithelia of endometriosis patients (Scotti et al., 2000; Poncelet et al., 2002) , while others observed no difference between cases and controls (Chen et al., 2002; Levy et al., 2008; Katy et al., 2010) . Interestingly, some other groups demonstrated increased levels of CDH1 in cases than in controls (Pannala et al., 2007; Matsuzaki et al., 2010) . In the present study we observed increased levels of CDH1 expression in cases than in controls. These findings strongly suggest that differential expression of CDH1 may have an important role in the shedding of viable endometrial cells during the menstrual cycle, peritoneal implantation, infiltrative growth and the development of malignancy. Further elucidation of the role of CDH1 and other cell adhesion molecules is necessary to define the pathogenesis of endometriosis.
The CDH1 expression seems to be genotype dependent (Fig. 5) . In overall, the 2160A, 2347GA and +54T alleles appear to decrease the CDH1 expression. The effect is more when the individuals carry homozygous mutated alleles (e.g. samples 5 and 7; 6 and 8 and 2 and 3). The effect also appears to be cooperative/additive (e.g. samples 7 and 8). Furthermore, case tissues showed high incidence of significant haplotypes (2347GA/2160A/+54C and 347G/2160A/+54C) than controls tissues (Fig. 5) . Interestingly, all the case tissues showed at least one significant haplotype, but the controls were not (except sample 4). Although, the case tissues are associated with significant genotypes, their expression levels are higher than in control tissues. Haplotype effect on expression may be one of the reasons for this discrepancy. Actually both associated SNPs (2347GA, 2160A) decrease the CDH1 expression by lowering the transcriptional efficiency (Li et al., 2002; Shin et al., 2004) . But here we cannot ignore the role of alleles at third loci (+54C/T) of the haplotypes. When we compare the significant haplotypes with their related haplotypes which differ only at the third locus [2347G/2160A/+54C (P ¼ 0.007) versus 2347G/2160A/+54T (P ¼ 0.152) and 2347GA/2160A/+54C (P , 0.0001) versus 347GA/2160A/+54T (P ¼ 0.113)], we can perceive the protective role of +54T allele. This allele (+54T) may decrease the CDH1 expression at post-transcriptional level by altering the m-RNA stability (Keirsebilck et al., 1998) . Our expression results are in agreement with this finding (Fig. 5, samples 2 and 3 ). Interestingly our case tissues carry at least one wild allele (C) at +54 loci. The negative posttranscriptional effect of +54T allele may be one of the reasons for the lower expression of CDH1 in controls than in cases even though the cases have associated polymorphisms that lowers the expression. In addition, the haplotype effect on CDH1 expression showed two different scenarios in cases and controls as the expression is more in cases than in controls for the same haplotype (e.g. samples 4 and 5). It indicates the involvement of some other unknown factors/mechanisms in CDH1 expression between cases and controls. Although the observations are interesting, we are not going to conclude the above CDH1 genotypes and haplotypes as direct cause of endometriosis because with this very small sample size, it is very difficult to decipher the impact of genotype/haplotype on expression as it (expression) is regulated by several cis and trans acting factors.
In conclusion, CDH1 2347GA/GA and 2160A/A genotypes and 2347GA/2160A/+54C and 2347G/2160A/+54C haplotypes may jointly modify the endometriosis risk in Indian women, whereas the remaining genotypes and haplotypes have comparatively lower risk. In addition, the differential expression of CDH1 may play an important role in pathogenesis of endometriosis. Additional, larger population-based studies as well as functional evaluation of the variants are necessary to confirm our findings.
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